Salmeterol
- TRADE NAMES: Advair (GSK); Salmeter; Serevent (GSK); Serobid; Zantirel
- INDICATIONS: Asthma
- CLASS: Beta-2 adrenergic agonist, Bronchodilator
- HALF-LIFE: 3–4 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alpha blockers, Aprepitant, Atazanavir, Beta blockers, Betahistine, Boceprevir, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Conivaptan, CYP3A4 inhibitors, Darunavir, Delavirdine, Efavirenz, Indinavir, Iobenguane, Lapatinib, Loop diuretics, Lopinavir, Ombitasvir/Paritaprevir/Ritonavir, Sympathomimetics, Telaprevir, Telithromycin, Tipranavir, Tricyclic antidepressants, Voriconazole
PREGNANCY CATEGORY: C
Advair is salmeterol and fluticasone.
ASTHMA-RELATED DEATH
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric